New Insights into the Pathogenesis of Type 1 Diabetes
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (20 November 2025) | Viewed by 1592
Special Issue Editor
Interests: autoimmunity; type 1 diabetes; endocrinopathies; T regulatory cells; autoreactive T cells; nanotechnologies; NK cells; extracellular vesicles; immunoregulation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Insulin-dependent diabetes mellitus (type 1 diabetes, T1D) is a multifactorial autoimmune disease with a strong genetic component. The disorder occurs in individuals genetically predisposed to human leukocyte antigen (HLA) as a consequence of organ-specific immune destruction of the insulin-producing cells in the islets of Langerhans within the pancreas. As a genetic background, dominant loci within the major histocompatibility complex (MHC) and the HLA region predisposing to the disease were recognized in both the NOD and human disease.
The pathogenesis of this multifactorial disorder requires the contribution of genetics, still-unknown environmental factors, and stochastic events. It is generally recognized that T1D derives from a breakdown in immune regulation that leads to the expansion of autoreactive CD4+ and CD8+ T cells, autoantibody-producing B lymphocytes, and activation of the innate immune system.
In this Special Issue, we discuss recent discoveries on the pathogenesis of T1D that constitute the background for the development of novel immunotherapies.
Dr. Alessandra Fierabracci
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- type 1 diabetes
- insulin-dependent diabetes mellitus
- human leukocyte antigen (HLA)
- pathogenesis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
